U.S. Biopharmaceutical company, AntriaBio establishes branch in Seoul
A biopharmaceutical company located in U.S. Colorado, which is developing a new extended release type of treatment, AntriaBio Inc. announced it will found an affiliate in Seoul and seek for plans to conduct R&Ds and manufacture pharmaceutical products.
AntriaBio is planning to complete fund-rais...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
